Insider · CIK 0002008764
Robert Joseph Smith
Files at CTXR (Citius Pharmaceuticals, Inc.), CTOR (CITIUS ONCOLOGY, INC.). First filing -, latest -.
In brief
Robert Joseph Smith files SEC Form 4 as director at CTXR (Citius Pharmaceuticals, Inc.), and also at CTOR (CITIUS ONCOLOGY, INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Robert Joseph Smith has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 19, 2025 | CTOR CITIUS ONCOLOGY, INC. | AGrant or award Common Stock | +300,000 | $0.00 | $0 | 300,000 | Dec 22, 2025 |
| Sep 19, 2025 | CTOR CITIUS ONCOLOGY, INC. | AGrant or award Common Stock | +300,000 | $0.00 | $0 | 300,000 | Dec 1, 2025 |
| Sep 19, 2025 | CTOR CITIUS ONCOLOGY, INC. | AGrant or award Common Stock | +300,000 | $0.00 | $0 | 300,000 | Sep 23, 2025 |
| Dec 12, 2024 | CTOR CITIUS ONCOLOGY, INC. | AGrant or award Stock Option (Right to Buy)derivative | +125,000 | $0.00 | $0 | 125,000 | Dec 16, 2024 |
| Nov 7, 2024 | CTXR Citius Pharmaceuticals, Inc. | AGrant or award Stock Option (Right to Purchase Common Stock)derivative | +125,000 | $0.00 | $0 | 125,000 | Nov 12, 2024 |
Questions about Robert Joseph Smith
Answered from the filings on this page, as of the latest one.
Is Robert Joseph Smith buying or selling?
Robert Joseph Smith has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Robert Joseph Smith's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Robert Joseph Smith has 0.
Where does Robert Joseph Smith file Form 4?
Robert Joseph Smith has filed Form 4 at CTXR (Citius Pharmaceuticals, Inc.); CTOR (CITIUS ONCOLOGY, INC.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.